Long-Term Predictive Value of a Single Cytomegalovirus (CMV) DNA PCR Assay for CMV Disease in Human Immunodeficiency Virus-Infected Patients

ABSTRACT Universal prophylaxis with oral ganciclovir is not cost-effective for the prevention of cytomegalovirus (CMV) disease in human immunodeficiency virus infection. For a preemptive strategy to be considered, patients at highest risk for CMV disease need to be easily and accurately identified. In this study, the sensitivity, specificity, positive predictive value, and negative predictive value of a single CMV DNA PCR assay for the subsequent development of CMV disease were 0.75, 0.89, 0.75, and 0.89, respectively.

[1]  M. Youle,et al.  Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy , 1997, The Lancet.

[2]  C. Sabin,et al.  Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV‐positive patients at high risk of CMV disease , 1997, AIDS.

[3]  H. Sacks,et al.  Cost‐effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing , 1997, AIDS.

[4]  B. Hofmann,et al.  Development of cytomegalovirus (CMV) disease may be predicted in HIV‐infected patients by CMV polymerase chain reaction and the antigenemia test , 1997, AIDS.

[5]  S. Spector,et al.  Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. , 1997, The Journal of infectious diseases.

[6]  M. Bergeron,et al.  Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System , 1997, Journal of Clinical Microbiology.

[7]  S. Walmsley,et al.  Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients , 1996, Journal of clinical microbiology.

[8]  P. Weinbreck,et al.  Interest of quantitative pp65 cytomegalovirus antigenemia assay for human immunodeficiency virus-positive patients , 1996, Journal of clinical microbiology.

[9]  W. Hardy.  Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease. , 1996, AIDS.

[10]  C. Sabin,et al.  Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival , 1996, AIDS.

[11]  D. Havlir,et al.  Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. , 1996, The New England journal of medicine.

[12]  H. Einsele,et al.  A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood , 1996, Journal of clinical microbiology.

[13]  P. Alcabes,et al.  Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  V. Diehl,et al.  CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  M. Boeckh,et al.  High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up , 1996, Journal of clinical microbiology.

[16]  M. Krajden,et al.  Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology , 1996, Journal of clinical microbiology.

[17]  T. Merigan,et al.  Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. , 1995, The Journal of infectious diseases.

[18]  S. Olofsson,et al.  Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. , 1994, The Journal of infectious diseases.

[19]  M. Hirsch,et al.  Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS , 1993, Journal of clinical microbiology.

[20]  T. Mazzulli.  Improved diagnosis of cytomegalovirus infection by detection of antigenemia or use of PCR methods , 1993 .

[21]  D. Peyramond,et al.  Polymerase chain reaction detection of cytomegalovirus DNA in peripheral blood leukocytes as a predictor of cytomegalovirus disease in HIV‐infected patients , 1993, AIDS.

[22]  G. Gerna,et al.  Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients , 1992, Journal of clinical microbiology.

[23]  J. Phair,et al.  Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. , 1992, Journal of acquired immune deficiency syndromes.

[24]  H. L. Hennis,et al.  Cytomegalovirus retinitis. , 1989, Survey of ophthalmology.

[25]  R. A. May,et al.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. , 1988, The Journal of infectious diseases.